|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 206.50 USD | +0.62% |
|
+44.96% | +58.00% |
| 02-06 | Markets Ask the Obvious Question | |
| 02-06 | Analyst recommendations: Crown Holdings, Meta Platforms, Roku, Alphabet, Qualcomm… |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.36 | -0.83 | 2.91 | -0.46 | -7.76 | |||||
Return on Total Capital | 1.51 | -0.92 | 3.21 | -0.52 | -8.68 | |||||
Return On Equity % | 1.08 | -3.39 | 5.05 | -2.64 | -16.69 | |||||
Return on Common Equity | 1.08 | -3.39 | 5.05 | -2.64 | -16.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 59.49 | 59.01 | 62.74 | 58.88 | 53.42 | |||||
SG&A Margin | 22.54 | 25.67 | 18.65 | 18.33 | 24.89 | |||||
EBITDA Margin % | 11.54 | 4.12 | 17.17 | 4.82 | -20 | |||||
EBITA Margin % | 9.53 | 1.62 | 14.97 | 1.54 | -24.38 | |||||
EBIT Margin % | 4.49 | -4.56 | 11.65 | -1.71 | -28.32 | |||||
Income From Continuing Operations Margin % | 1.41 | -8.03 | 8.92 | -4.41 | -32.69 | |||||
Net Income Margin % | 1.41 | 293.73 | 8.92 | -4.41 | -32.69 | |||||
Net Avail. For Common Margin % | 1.41 | -8.03 | 8.92 | -4.41 | -32.69 | |||||
Normalized Net Income Margin | 1.02 | -3.88 | 8.05 | -1.26 | -16.56 | |||||
Levered Free Cash Flow Margin | 11.21 | 25.87 | 5.94 | -3.99 | 9.16 | |||||
Unlevered Free Cash Flow Margin | 11.2 | 25.41 | 6.15 | -3.67 | 9.3 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.48 | 0.29 | 0.4 | 0.43 | 0.44 | |||||
Fixed Assets Turnover | 5.55 | 4.27 | 5.83 | 4.48 | 3.58 | |||||
Receivables Turnover (Average Receivables) | 10.38 | 7.45 | 12.07 | 15.53 | 13.95 | |||||
Inventory Turnover (Average Inventory) | 5.14 | 6.08 | 5.1 | 2.18 | 1.82 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.43 | 3.35 | 7.87 | 4.51 | 6.15 | |||||
Quick Ratio | 2.88 | 3.2 | 6.8 | 2.86 | 4.51 | |||||
Operating Cash Flow to Current Liabilities | 0.48 | -0.15 | 0.39 | -0.19 | -0.14 | |||||
Days Sales Outstanding (Average Receivables) | 35.73 | 48.85 | 30.17 | 23.44 | 26.09 | |||||
Days Outstanding Inventory (Average Inventory) | 72.16 | 59.85 | 71.42 | 166.75 | 200.55 | |||||
Average Days Payable Outstanding | 49.35 | 62.69 | 57.71 | 64.54 | 99.11 | |||||
Cash Conversion Cycle (Average Days) | 58.55 | 46.01 | 43.88 | 125.64 | 127.53 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 49.45 | 21.69 | 39.42 | 5.96 | 1.98 | |||||
Total Debt / Total Capital | 33.09 | 17.82 | 28.27 | 5.62 | 1.95 | |||||
LT Debt/Equity | 37.68 | 1 | 38.97 | 1.64 | 1.44 | |||||
Long-Term Debt / Total Capital | 25.21 | 0.82 | 27.95 | 1.55 | 1.41 | |||||
Total Liabilities / Total Assets | 39.81 | 25.21 | 35.24 | 16.24 | 11.67 | |||||
EBIT / Interest Expense | 1.17 | -1.06 | 17.74 | -2.4 | -126.33 | |||||
EBITDA / Interest Expense | 3.16 | 1.2 | 27.24 | 8.2 | -83.36 | |||||
(EBITDA - Capex) / Interest Expense | 2.56 | 0.28 | 23.3 | 4.19 | -92.33 | |||||
Total Debt / EBITDA | 5.5 | 12.93 | 3.02 | 1.58 | -0.2 | |||||
Net Debt / EBITDA | -1.22 | -42.01 | -3.48 | -8.07 | 3.3 | |||||
Total Debt / (EBITDA - Capex) | 6.78 | 56.17 | 3.54 | 3.1 | -0.18 | |||||
Net Debt / (EBITDA - Capex) | -1.5 | -182.58 | -4.07 | -15.8 | 2.98 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.86 | 41.09 | 42.07 | -23.62 | -25.3 | |||||
Gross Profit, 1 Yr. Growth % | 3.38 | 44.28 | 51.05 | -28.32 | -32.22 | |||||
EBITDA, 1 Yr. Growth % | -9.59 | -163.57 | 491.75 | -78.55 | -534.16 | |||||
EBITA, 1 Yr. Growth % | -12.16 | -118.51 | 1.21K | -92.16 | -11.78K | |||||
EBIT, 1 Yr. Growth % | -29.8 | -68.9 | -463.18 | -111.2 | 585.15 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -34.95 | -49.89 | -257.93 | -137.76 | 453.4 | |||||
Net Income, 1 Yr. Growth % | -34.95 | 16.8K | -95.68 | -137.76 | 453.4 | |||||
Normalized Net Income, 1 Yr. Growth % | -70.68 | -65.31 | -394.63 | -112.15 | 482.6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -34.88 | -48.82 | -287.97 | -142.91 | 444.37 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.82 | 3.3 | -27.34 | -58.99 | 85.97 | |||||
Inventory, 1 Yr. Growth % | -8.75 | 3.02 | 103.66 | 93.49 | -45.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 10.28 | 6.87 | 1.33 | -2.32 | -10.98 | |||||
Total Assets, 1 Yr. Growth % | 19.02 | 48.4 | -26.67 | -33.48 | -15.27 | |||||
Tangible Book Value, 1 Yr. Growth % | -31 | 160.17 | -45.04 | -18.11 | -13.67 | |||||
Common Equity, 1 Yr. Growth % | 7.6 | 84.39 | -36.49 | -13.97 | -10.64 | |||||
Cash From Operations, 1 Yr. Growth % | -18.5 | -174.01 | -171.49 | -142.26 | -54.17 | |||||
Capital Expenditures, 1 Yr. Growth % | 25.45 | 57.99 | -7.18 | -16 | -47.28 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -16.48 | 5.43K | -67.5 | -151.4 | -240.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -15.96 | 5.49K | -65.7 | -145.62 | -253.22 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.05 | 23.35 | 41.58 | 4.17 | -24.46 | |||||
Gross Profit, 2 Yr. CAGR % | 0.59 | 23.21 | 47.62 | 4.05 | -30.3 | |||||
EBITDA, 2 Yr. CAGR % | -16.06 | -8.78 | 90.91 | 12.67 | -18.47 | |||||
EBITA, 2 Yr. CAGR % | -17.18 | -52.13 | 54.16 | 1.5 | -3.61 | |||||
EBIT, 2 Yr. CAGR % | -31.66 | -39.14 | 5.53 | -36.23 | 17.8 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -61.28 | -24.92 | -11.04 | -22.77 | 44.56 | |||||
Net Income, 2 Yr. CAGR % | -61.28 | 948.38 | 170.08 | -87.23 | 44.56 | |||||
Normalized Net Income, 2 Yr. CAGR % | -55.2 | -31.67 | 0.51 | -40.43 | 9.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -61.61 | -24.49 | -1.91 | -10.19 | 52.84 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.03 | 14.01 | -13.36 | -45.41 | -12.67 | |||||
Inventory, 2 Yr. CAGR % | -5.7 | -17.85 | 44.85 | 98.51 | 2.57 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.8 | 7.11 | 4.07 | -0.51 | -6.75 | |||||
Total Assets, 2 Yr. CAGR % | 10.78 | 32.9 | 4.32 | -30.16 | -24.93 | |||||
Tangible Book Value, 2 Yr. CAGR % | -10.27 | 71.71 | 19.58 | -32.91 | -15.92 | |||||
Common Equity, 2 Yr. CAGR % | 6.03 | 40.86 | 8.21 | -26.09 | -12.32 | |||||
Cash From Operations, 2 Yr. CAGR % | -11.57 | -22.33 | -27.26 | -45.03 | -55.99 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.63 | 36.67 | 21.1 | -11.7 | -33.45 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 3.52 | 250.5 | 399.8 | -59.13 | -6.14 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 3.79 | 257.33 | 418.91 | -60.44 | -7.09 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.87 | -6.01 | 29.3 | 15.26 | -6.76 | |||||
Gross Profit, 3 Yr. CAGR % | 5.12 | -6.56 | 31.87 | 16.03 | -9.8 | |||||
EBITDA, 3 Yr. CAGR % | -6.95 | -41.07 | 70.12 | -7.87 | 57.86 | |||||
EBITA, 3 Yr. CAGR % | -8.98 | -54.42 | 44.41 | -42.89 | 130.27 | |||||
EBIT, 3 Yr. CAGR % | -22.34 | -27.23 | 10.4 | -50.04 | 71.45 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -35.68 | -11.53 | -3.8 | -33.14 | 48.89 | |||||
Net Income, 3 Yr. CAGR % | -35.68 | 193.68 | 68.03 | 40.18 | -55.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | -42.67 | -14.72 | 11.22 | -50.57 | 51.58 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -36.43 | -10.74 | 2.34 | -25.54 | 63.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.07 | 10.33 | -1.89 | -32.48 | -17.86 | |||||
Inventory, 3 Yr. CAGR % | -3.04 | -13.04 | 11.19 | 59.52 | 28.92 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.5 | 7.85 | 5.15 | 1.89 | -4.13 | |||||
Total Assets, 3 Yr. CAGR % | 9.1 | 22.12 | 9.01 | -10.21 | -25.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | -11.6 | 50.96 | 17.46 | 5.4 | -27.03 | |||||
Common Equity, 3 Yr. CAGR % | 7.98 | 27.51 | 8.01 | 0.24 | -21.26 | |||||
Cash From Operations, 3 Yr. CAGR % | -10.53 | -16.66 | -24.45 | -39.3 | -48.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | 18.57 | 5.32 | 20.13 | 7.2 | -25.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -15.32 | 26.2 | 58.79 | 134.16 | -34.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -15.12 | 25.7 | 63.75 | 130.73 | -33.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.58 | 0.66 | 5.9 | -2.06 | 4.29 | |||||
Gross Profit, 5 Yr. CAGR % | 6.59 | 0.18 | 7.19 | -2.45 | 2.18 | |||||
EBITDA, 5 Yr. CAGR % | 5.53 | -22.63 | 6.73 | -23.63 | 26.76 | |||||
EBITA, 5 Yr. CAGR % | 6.04 | -34.06 | 6.47 | -37.22 | 22.85 | |||||
EBIT, 5 Yr. CAGR % | 1.73 | -13.1 | 7.01 | -30.97 | 13.3 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -15.79 | -1.21 | 14.18 | -16.21 | 13.22 | |||||
Net Income, 5 Yr. CAGR % | -15.79 | 102.95 | 14.18 | -16.21 | 58.22 | |||||
Normalized Net Income, 5 Yr. CAGR % | -15.96 | -7.04 | 11.4 | -26.23 | 10.05 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -16.5 | -1.4 | 18.44 | -10.52 | 20.15 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.27 | 5.73 | 0.02 | -16.73 | -6.35 | |||||
Inventory, 5 Yr. CAGR % | 4.34 | -3.71 | 6.55 | 20.98 | 7.65 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.04 | 6.13 | 6.72 | 4.42 | 0.22 | |||||
Total Assets, 5 Yr. CAGR % | 14.53 | 22.29 | 7.16 | -2.34 | -6.1 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.83 | 30.87 | 10.16 | 9.14 | 2.75 | |||||
Common Equity, 5 Yr. CAGR % | 9.53 | 21.75 | 8.07 | 2.52 | -0.64 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.18 | -4.87 | -17.64 | -29.44 | -39.13 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.63 | 21.2 | 16.71 | -1.85 | -5.15 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.84 | 13.01 | -17.98 | -19.56 | 28.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.41 | 12.24 | -17.26 | -20.8 | 30.54 |
- Stock Market
- Equities
- SLAB Stock
- Financials Silicon Laboratories Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















